Valuation : FDC Limited

Market Cap 52.29B 548M 470M 440M 403M 759M 761M 5.21B 2.04B 26.36B 2.06B 2.01B 87.23B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 494M 424M 397M 363M 684M 686M 4.7B 1.84B 23.76B 1.85B 1.81B 78.64B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
5.15%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.98%
1 week-0.25%
Current month-16.09%
1 month-17.56%
3 months-14.71%
6 months-5.33%
Current year-18.73%
1 week 340.25
Extreme 340.25
353.05
1 month 339.1
Extreme 339.1
425.05
Current year 312.95
Extreme 312.95
442
1 year 312.95
Extreme 312.95
527.8
3 years 312.95
Extreme 312.95
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 01/04/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.98%-0.25% - - 595M
+0.03%-4.63%+61.66%+114.26% 1,060B
-1.11%-0.16%+51.00%+62.49% 651B
-1.68%-1.29%+24.22%+75.31% 465B
-1.17%-2.10%+38.61%+40.46% 365B
-2.00%-1.35%+22.22%+37.78% 300B
-0.98%+0.53%+2.04%+12.13% 258B
-0.20%+1.45%+52.80%+71.51% 238B
-3.18%-0.30%-17.23%-54.33% 210B
+0.20%+3.36%+30.14%+92.45% 184B
Average -1.05%-0.66%+29.50%+50.23% 414.49B
Weighted average by Cap. -0.88%-2.16%+39.02%+66.64%

Financials

2024 2025
Net sales 19.43B 203M 175M 163M 150M 282M 283M 1.94B 757M 9.79B 764M 747M 32.41B 21.08B 221M 189M 177M 162M 306M 307M 2.1B 821M 10.62B 829M 811M 35.16B
Net income 3.05B 31.96M 27.43M 25.68M 23.52M 44.3M 44.43M 304M 119M 1.54B 120M 117M 5.09B 2.67B 27.93M 23.98M 22.45M 20.56M 38.72M 38.83M 266M 104M 1.34B 105M 103M 4.45B
Net Debt -4.55B -47.63M -40.89M -38.28M -35.05M -66.03M -66.22M -453M -177M -2.29B -179M -175M -7.59B -5.15B -53.92M -46.28M -43.33M -39.68M -74.74M -74.96M -513M -201M -2.6B -202M -198M -8.59B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
27/08/26 343.85 -0.98% 84,955
26/08/26 ₹347.25 +1.05% 134,656
25/08/26 ₹343.65 -0.19% 97,739
24/08/26 ₹344.30 -1.23% 165,195
21/08/26 ₹348.60 -0.44% 96,904
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B